Europe News
AstraZeneca profit rises 23% as cancer medicines drive growth and savings plan begins
AstraZeneca’s third-quarter profit rose 23% as cancer-drug sales grew, while the company announced a $1.5bn annual savings plan.
AstraZeneca’s third-quarter profit rose 23% as cancer-drug sales grew, while the company announced a $1.5bn annual savings plan.
Subscribe to DailyDigest notifications for the latest news and updates.